Background-Differences in cardiovascular disease (CVD) burden exist among racial/ethnic groups in the United States, with African-Americans having the highest prevalence. Subclinical CVD measures have also been shown to differ by race or ethnicity. In the United States, there has been a significant intermixing among racial/ethnic groups creating admixed populations. Very little research exists on the relationship of genetic ancestry and subclinical CVD measures. Methods and Results-These associations were investigated in 712 black and 705 Hispanic participants from the Multi-Ethnic Study of Atherosclerosis candidate gene substudy. Individual ancestry was estimated from 199 genetic markers using STRUCTURE. Associations of ancestry and coronary artery calcium (CAC) and common and internal carotid intima media thickness were evaluated using log-binomial and linear regression models. Splines indicated linear associations of ancestry with subclinical CVD measures in African-Americans but presence of threshold effects in Hispanics. Among AfricanAmericans, each SD increase in European ancestry was associated with an 8% (95% CI, 1.02 to 1.15; Pϭ0.01) higher CAC prevalence. Each SD increase in European ancestry was also associated with a 2% (95% CI Ϫ3.4% to Ϫ0.5%, Pϭ0.008) lower common carotid intima media thickness in African-Americans. Among Hispanics, the highest tertile of European ancestry was associated with a 34% higher CAC prevalence (Pϭ0.02) when compared with the lowest tertile. Conclusions-The linear association of ancestry and subclinical CVD suggests that genetic effects may be important in determining CAC and carotid intima media thickness among African-Americans. Our results also suggest that CAC and common carotid intima media thickness may be important phenotypes for further study with admixture mapping. (Circ Cardiovasc Genet. 2009;2:629-636.)
T he burden of cardiovascular disease (CVD) disproportionately affects certain racial/ethnic groups. 1 In addition, the presence and amount of subclinical cardiovascular CVD measures such as coronary artery calcium (CAC) and carotid intima media thickness (cIMT) differ by race or ethnicity. [2] [3] [4] [5] [6] [7] [8] [9] [10] For example, generally, African-Americans have less CAC but larger cIMT than that of Caucasions. [2] [3] [4] [5] [6] [7] [8] [9] [10] Hispanic Americans tend to have less CAC than that of Caucasions and smaller cIMT measures than that of AfricanAmericans. 2,3,10 -12 Whether these differences may be partly due to differences in genetic predisposition is unknown.
Clinical Perspective on p 636
Complex chronic diseases such as CVD are likely caused by many genetic and environmental factors and their interactions. Assessing associations of self-reported race or ethnicity with complex diseases is often complicated because of the heterogeneity within the racial/ethnic groups. In United States, there has been a significant intermixing among racial/ethnic groups, thereby creating populations that are a mosaic of multiple continental ancestral populations (European, African, and Native American). 13, 14 These admixed populations can be used to determine whether there is an association between ancestry and a disease phenotype and may lead to identification of important differences in risk as well as clues to causal genetic loci.
We can quantify the percentage of different ancestries for a given individual by using ancestry informative markers (AIMs) to estimate individual ancestry (IA). AIMs are markers that have large allele frequency differences among different populations and thus perform well in distinguishing ancestry groups. 15 Studies of associations of IA and phenotypic traits or diseases can help to identify those traits or diseases for which admixture mapping, a method for efficiently mapping complex traits, would be a successful approach. 16 In addition, failure to adequately control for population stratification in genetic association studies can lead to spurious results. 17, 18 IA estimates can be used to more precisely control for population stratification in genetic association studies of admixed populations. 17, 18 Only 2 previous studies have examined the association between genetic ancestry and subclinical CVD in AfricanAmericans 17, 19 ; however, these studies used a substantially smaller number of AIMs. Whether genetic ancestry is associated with subclinical CVD in Hispanics is unknown. Thus, this study examined the association of genetic ancestry with CAC prevalence ratio and common and internal cIMT in African-Americans and Hispanic Americans from the MultiEthnic Study of Atherosclerosis (MESA).
Methods

Participants
MESA participants were recruited from 6 field sites in the United States: Forsyth County, NC (Wake Forest), Northern Manhattan/ Bronx, NY (Columbia), Baltimore/Baltimore County, Md (Johns Hopkins), St Paul, Minn (University of Minnesota), Chicago, Ill (Northwestern), and Los Angeles County, Calif (UCLA). Details of recruitment have been previously published. 20 Briefly, MESA recruited 6814 men and women aged 45 to 84 years without CVD. The cohort was 53% women with a racial/ethnic composition of Ϸ38% white, 28% black, 23% Hispanic, and 11% Asian (primarily of Chinese descent). A subsample of 2847 MESA participants was selected for a candidate gene study from participants who gave informed consent for DNA extraction. Overall, the candidate gene study included 712 black, 705 Hispanic, 718 Chinese, and 712 white participants and approximately equal numbers of men and women. In general, Caucasions of Northern European descent such as those in MESA and Chinese groups show very little admixture (Ͻ5%) with other populations; hence this study concentrates only on estimating ancestry in the black and Hispanic groups, using Caucasions as a pseudoancestral group.
Selection of AIMs and Genotyping
AIMs were genotyped on the MESA candidate gene subsample in 2 separate panels and were chosen to maximize allele frequency differences among ethnic groups. In panel 1, a total of 96 AIMs were selected from an Illumina proprietary single-nucleotide polymorphism database to maximize the difference in allele frequencies between white and black, white and Chinese, or black and Chinese groups. An additional 103 AIMs genotyped in panel 2 were selected from published lists and were informative for Hispanic ancestry. 21, 22 A list of the AIMs, along with the minor allele and minor allele frequencies for all 4 MESA ethnic groups, is included in supplemental Table I. Illumina Genotyping Services (Illumina, Inc, San Diego, Calif) performed genotyping using the GoldenGate assay. Illumina performed initial quality control in their laboratory to identify samples and single-nucleotide polymorphisms that failed genotyping according to protocols and to identify sporadic failed genotypes with poor GenCall quality scores (Ͻ0.25). In panel 1, there was a 99.8% sample and 93.7% single-nucleotide polymorphism success rates, and an overall genotype call rate of 99.93%. In panel 2, there was a 99.7% sample and 95.5% single-nucleotide polymorphism success rates, and an overall genotype call rate of 99.3%.
Outcomes and Covariates
Both common and internal cIMT were measured at baseline by high-resolution B-mode ultrasonography, and reading was performed centrally at the MESA ultrasound reading center (Tufts-New England Medical Center, Boston, Mass). Baseline CAC was measured by computed tomography, and scans were read at the central MESA CT reading center (Harbor-University of California Medical Center, Los Angeles, Calif). Further information on the reading of scans and calculation of Agatston scores has been published elsewhere. 11 Further details on cIMT and CAC measurement can be found in the supplemental methods.
Information on age, gender, ethnicity, smoking, alcohol use, education, and annual household income was obtained through a baseline interview and questionnaires. Waist circumference, systolic and diastolic blood pressures, triglycerides, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, fasting glucose, and C-reactive protein were all measured using standard methods and assays. Further details on the methods and additional covariate definitions can be found in the supplementary methods.
Characterization of Population Structure and Estimation of Genetic Admixture
Deviations from Hardy-Weinberg Equilibrium (HWE) were evaluated separately in different ethnic groups, and by gender for X chromosome markers, for the 199 AIMs using exact tests. 23 Those markers that were not in HWE were still used, because it was expected that there may be deviations from HWE in populations with substructure, especially at AIMs, and that this would tend to favor excess homozygosity. 24 To obtain IA estimates and to determine the appropriate number of ancestral populations (K) for African-Americans and Hispanics, STRUCTURE version 2.2 was used, which uses a Bayesian Markov Chain Monte Carlo approach. 25 Pseudoancestral population genotype data were obtained from HapMap (60 Yoruban Nigerians), and previous genotype data were collected on 345 participants from Native American populations. 21, 22 Genotype data from the 712 MESA Caucasions were also used as pseudoancestors.
Tests of Association Between Admixture and Subclinical CVD Measures
Baseline characteristics were compared across racial/ethnic groups using ANOVA, 2 , or Kruskal-Wallis tests as appropriate. To assess the appropriate functional form of ancestry with subclinical CVD outcomes, generalized additive models with a cubic B-spline function were used. Percent ancestry was modeled as continuous per SD except where splines indicated otherwise.
PR was modeled as a dichotomous outcome (CACϾ0 versus CACϭ0). Because prevalence ratio was much Ͼ10%, log-binomial models with a log link and binomial error distribution were used to assess associations of ancestry with prevalence ratio, because odds ratios from logistic regression will overestimate the prevalence ratios. 26 In cases where the log binomial model did not converge, a Gaussian error distribution with robust SEs was used. Common and internal cIMT were ln-transformed, and a linear regression was used; the results for these models are presented as percent increase or decrease in the outcome per SD increase in ancestry using the transformation (e ␤ Ϫ1)ϫ100. Staged models were used to examine the effects of potential confounders. Spline analyses were performed in SPlus Version 6.1; other analyses were performed in SAS version 9.1 (SAS Institute, Cary, NC). Results with PϽ0.05 were considered statistically significant. Table 1 shows characteristics for the MESA candidate gene substudy by self-reported racial/ethnic group. All characteristics except age, gender, current smoking, low-density lipoprotein cholesterol, and lipid-lowering medication use differed significantly across racial/ethnic groups (Table 1) .
Results
Participant Characteristics
Self-Reported Race or Ethnicity and Subclinical CVD
Hispanics had significantly lower internal cIMT than did Caucasions (Pϭ0.003), whereas internal cIMT levels for African-Americans did not significantly differ from Caucasions (Pϭ0.82). Common cIMT was significantly higher for African-Americans than for Caucasions (PϽ0.001). Common cIMT measures did not differ between Hispanics and Caucasions (Pϭ0.41). The prevalence ratio was higher for Caucasions than for both African-Americans (PϽ0.001) and Hispanics (PϽ0.001).
Admixture and Population Substructure
For African-Americans, 11 of 199 non-X chromosome AIMs were out of HWE (PϽ0.05); among the 96 markers used to estimate IA for the African-Americans, 6 were out of HWE. Of 199 non-X chromosome AIMs, 5 were out of HWE for the white group and 61 for the Hispanics. Twenty-two AIM pairs for African-Americans, 9 pairs for Chinese, 10 pairs for Caucasions, and 14 pairs for Hispanics had pairwise linkage disequilibrium (r 2 ) Ն0.20. The average ␦, or average allele frequency difference between the pseudoancestral populations, was 0.50 for black versus white. For the Native American and white groups, the average ␦ was 0.32, and for the African-Americans and Native Americans, it was 0.47.
For the African-Americans, using 96 AIMs and the HapMap Yoruban Nigerians and MESA Caucasions as ancestral groups, STRUCTURE determined that 2 ancestral populations were appropriate for African-Americans. For Hispanics, using 199 markers and the HapMap Yoruban Nigerians, MESA white, and external Native American ancestral groups, STRUCTURE determined that 3 ancestral populations were likely adequate. It was also confirmed that the MESA Caucasions had Ͼ97% European ancestry on average and thus were acceptable for use Figures 1 and 2 . Differences in ancestry estimates were significant across field sites for both African-Americans (PϽ0.001 for European ancestry) and Hispanics (PϽ0.001 for European and African ancestry, Pϭ0.002 for Native American ancestry).
Associations Between Ancestry and CAC
A spline of percent European ancestry with prevalence ratio among the African-Americans indicated an approximately linear association. Among Hispanics, splines indicated that the associations of both European and Native American ancestry with prevalence ratio were possibly nonlinear; however, only the quadratic term in the prevalence ratio model was significant (Pϭ0.03). It was determined that European and Native American ancestry terms in the prevalence ratio model for Hispanics could be categorized into tertiles to facilitate interpretation.
Among the African-Americans, an SD (15.9%) increase in percent European ancestry was significantly associated with an 18% higher prevalence ratio in an unadjusted model and an 8% higher prevalence ratio in a fully adjusted model (Table 2) . Because African ancestry is a complement of European ancestry in this case, each SD increase in African ancestry (15.9%) was associated with 7% lower prevalence ratio (0.93; 95% CI, 0.87 to 0.98; Pϭ0.01) in a fully adjusted model. Analyses investigat- ing the association of European ancestry with CACϾ10 versus CACՅ10 yielded similar results.
Among Hispanics, the highest tertile of European ancestry (Ն48.4%) was associated with higher prevalence ratio compared with the lowest tertile of European ancestry (Յ26.7%; Table 3 ). Adjustment for potential confounders attenuated this association, with a roughly 33% decrease in the prevalence ratio for the highest tertile of European ancestry (Table 3 ). In fully adjusted models, the highest tertile of European ancestry was associated with a 34% higher prevalence ratio compared with the lowest tertile (Pϭ0.02). Associations of the highest tertile of Native American ancestry and prevalence ratio were similar to those of tertile 3 of European ancestry, although marginally significant ( Table 3) . As a confirmatory analysis, we examined the association of African ancestry and prevalence ratio among Hispanics. In a fully adjusted model containing both African and Native American ancestry, each SD in African ancestry (18.9%) was marginally associated with a lower prevalence ratio (prevalence ratio, 0.91; 95% CI, 0.82 to 1.01; Pϭ0.07); Native American ancestry was not associated with prevalence ratio (0.99; 95% CI, 0.92 to 1.07; Pϭ0.80). These results are consistent with the findings of models including European and Native American ancestry. Analyses investigating the association of ancestry with CAC Ͼ10 versus CAC Յ10 among Hispanics yielded similar results.
Associations Between Ancestry and cIMT
Splines of percent European ancestry with the natural logarithm of common and internal cIMT among the African-Americans indicated approximately linear associations. Among Hispanics, a spline showed that the association of European ancestry with common cIMT was approximately linear. Splines indicated the associations of European and Native American ancestry with internal cIMT, and the association of Native American ancestry with common cIMT appeared nonlinear. However, quadratic ancestry terms in these models were not significant. †Includes age, site, gender, education, and income. ‡Additional adjustment for body mass index, waist circumference, current smoking, current alcohol use, prevalent diabetes, chronic kidney disease, and hypertension.
§Additional adjustment for fasting plasma glucose, triglycerides, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and C-reactive protein.
European ancestry was significantly associated with common cIMT but not internal cIMT among African-Americans. Each 1 SD in percent European ancestry was associated with a 2.0% (95% CI, 3.4% to 0.5%) lower common cIMT in fully adjusted models, Pϭ0.008 (Table 2) . Each SD increase was associated with a 1.7% lower (95% CI, Ϫ5.1 to 1.9; Pϭ0.35) internal cIMT. Because African ancestry is the complement to European ancestry in this case, each SD increase in African ancestry was associated with a 2.0% larger common cIMT and a 1.7% larger internal cIMT.
European and Native American ancestries were not significantly associated with common or internal cIMT in Hispanics (supplemental Table III ), although there was some suggestion of higher European ancestry being associated with lower common cIMT in fully adjusted models (Ϫ1.7%; 95% CI, Ϫ3.7% to 0.2%; Pϭ0.09). There seemed to be substantial confounding effects of the demographic variables for both cIMT outcomes (supplemental Table III ).
Discussion
Differences in the prevalence of subclinical CVD among different populations have been previously reported, but whether these differences reflect genetically determined ancestry are not known. Our study found that ancestry is associated with measures of subclinical CVD, and that these associations vary within racial/ethnic groups. Among selfreported African-Americans, we found that European ancestry was associated with prevalence ratio and common cIMT. Among self-reported Hispanics, European ancestry was positively associated with prevalence ratio, and Native American ancestry was positively marginally associated with prevalence ratio. However, ancestry was not significantly associated with internal cIMT among either African-Americans or Hispanics, or with common cIMT among Hispanics. The linear associations of ancestry with prevalence ratio and common cIMT suggest that genetic effects may indeed be important for African-Americans. The somewhat nonlinear association of ancestry and prevalence ratio among Hispanics could indicate that there are significant gene-gene or gene-environment interactions, or also possibly that there is a threshold of ancestry at which there may be significantly higher prevalence ratio. Alternatively, genetics may not play as important a role in subclinical CVD for Hispanics.
Our results are in accordance with previous literature, suggesting that the burden of CVD varies by race or ethnicity. In particular, it is known that white persons have higher prevalence ratio and African-Americans have larger common cIMT, 2-10 whereas Hispanic persons tend to have less CAC than Caucasions but larger cIMT than African-Americans. 2,3,10 -12 In terms of the ancestral composition and population substructure of black and Hispanic ethnic groups in MESA and differences observed by field site, our results are also consistent with previous studies. 17, 19, 27, 28 These findings are clinically relevant, given that subclinical CVD measures, especially CAC, seem to be important intermediate phenotypes in the pathway to clinical CVD. 29 This also holds clinical relevance, because it shows that even within a self-reported ethnic group, the risk for subclinical CVD can vary by the amount of a particular ancestral background. In addition, these results have important genetic implications because they suggest that (1) controlling for population stratification in multicenter genetic association studies to avoid spurious findings is important and (2) these phenotypes are good candidates for admixture mapping to find the possible causative loci underlying subclinical CVD. 30 -32 Admixture mapping has recently been successfully used to find variants associated with many complex diseases and risk factors. [33] [34] [35] [36] [37] [38] [39] Our study is novel in that we are the first to report associations between genetic ancestry and subclinical CVD among Hispanics, and it significantly contributes to previously conflicting literature on ancestry and CVD among African-Americans. Those studies with African-Americans were limited in that they used skin reflectance measurements as a surrogate for genetic admixture or too few markers to determine ancestry with precision. 17, 19, 40 Among AfricanAmericans in the Cardiovascular Health Study, Reiner et al 19 found that African ancestry was not significantly associated with common cIMT. In the Coronary Artery Risk in Young Adults study, Reiner et al 17 did not find African ancestry associated with CAC. However, these studies used a small number of AIMs (24 to 44) to estimate ancestry, which can lead to error in the ancestry estimates and false-negative results. 14, 41 Specifically, this should tend to bias results toward the null hypothesis because the error in measuring IA should be random with respect to the outcomes in the studies, 27 which could partially explain the discrepancies between our study and those of Reiner et al.
The use of race or ethnicity to define groups is controversial. 13, 14, [42] [43] [44] [45] Confusion surrounding the definitions of race, ethnicity, and ancestry has added to this controversy. 14, 42 Race categories emphasize geographic location of ancestry, whereas ethnic background is a broader term generally referring to cultural tradition, common history and religion, and sometimes a shared genetic heritage. 13 Ancestry refers to an objective measure of genetic similarities and/or differences in individuals between and among populations. 42 Although in complex diseases such as CVD it is unlikely that the influence of allele frequency differences at a single locus will produce population-level differences in disease prevalence or incidence between ethnicities, multiple loci or genes such as this in addition to environmental factors may in fact work together to produce these population-level differences, which can lead to difference in risk by ancestral background. However, reasons other than genetic determinants for racial/ ethnic disparities in chronic disease prevalence and incidence in the United States, including access to good health care, adequate health insurance, socioeconomic status, diet, and other environmental factors should not in any way be discounted. 13 Specifically in the context of subclinical CVD, traditional cardiovascular risk factors do not explain the racial/ethnic differences. However, it has been hypothesized that vitamin D or calcium metabolism, bone regulatory markers, inflammatory markers, hemostasis, fibrinolysis, and/or genetic variants may explain these differences. 12 One of the main strengths of this study is the large number of AIMs with which to estimate ancestry. We had a total of 199 AIMs, 96 of which characterized differences in Euro-pean, African, and Chinese ancestry, and 103 of which were informative for Hispanic ancestry. Most previous studies have primarily concentrated on African-Americans; this study also includes a group of well-characterized Hispanics from different sites in the United States. This study had good pseudoancestral data from black, European, and Native American samples, which helps to prevent biased estimates of ancestry. 46 Finally, this study had excellent, standardized measures of subclinical CVD and complete covariate information, which made it possible to assess potential confounding of the ancestry and subclinical CVD associations.
Some limitations of this study should also be noted. Although we had substantial variation in ancestry estimates, there were only 39 African-Americans with European ancestry Ն50% and only 44 Hispanics with African ancestry Ն50%. More participants with greater variation in ancestry are needed to more accurately assess the associations of ancestry and subclinical CVD in populations with a more varied distribution of ancestry. The proportions of ancestry in MESA could differ from those of the general population, possibly because of those of mixed ancestry being less likely to enroll in a study such as this. Examining the associations of individual percent ancestry and subclinical CVD measures is not as conclusive as an admixture mapping study that could identify loci underlying subclinical CVD variants. Although there were strict quality control measures in MESA, measurement error inherent in the subclinical CVD measures still exists. Finally, even though we attempted to account for all known confounders, there could still be unknown confounders or residual confounding present.
In summary, we found that ancestry is associated with subclinical CVD among 2 admixed populations. Although the use of race or ethnicity remains controversial in the literature; this study suggests that genetic mechanisms may, at least in part, contribute to some of the differences observed. The linearity of ancestry-subclinical CVD association in AfricanAmericans supports this genetic mechanism hypothesis more so than the nonlinear threshold effects that we observed in the Hispanics. Future studies should focus on understanding other important gene-environment interactions that may be in the causal pathway of these observed associations. In addition, admixture mapping studies for these traits in AfricanAmericans and Hispanics are needed to find risk variants or alleles, with subsequent fine mapping to determine the exact variants responsible.
